However, if one disregards his input and focuses on the rest of the presentation, linked here, some of the ideas presented are already in work.
A few (and growing number) of us conceptually understand, ‘normal’ is never coming back.
Some, like Amandha Vollmer have openly discussed implementing the ‘parallel’ society.
This just out from Stew Peters, has his guest (DeAnna Lorraine) suggesting at time stamp 4:50, nurses and doctors that have quit (and there are a lot of them) in protest over not getting injected should start their own healthcare system.
The ‘parallel’ idea is out in the open; possibly gaining steam.
Forming that type of structure needs all the skills of the existing (corrupt) one. Engineers, technicians, skilled craftsman and on.
In that type of system there won’t be any ‘diverse workforce initiatives’. Just imagine, you’ll be hired paid and promoted based on your performance. 🙂
Stay Tuned
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
First, the daily chart with the familiar trendlines
The magenta arrow shows, down-thrust has diverged. Today closed lower but thrust energy was (nearly) nonexistent.
The right side trend is still unknown.
More contact points are needed. However, inverse fund LABD has shown consistent trend angles (above) at various points throughout its sideways, corrective move.
Taking the SPBIO hourly chart and inverting, gives a more accurate picture; we see the Wyckoff set-up:
This type of price action is high probability. Not perfect, but still potentially 75% – 80%, effective or higher.
The fact that inverse tracking fund LABD accelerated upward into the close adds weight, we’re potentially at the end of the correction.
The fundamental backdrop continues to implode.
The plan for world control (through speck injected depopulation) is out in the open now. No doubt.
Amandha Vollmer has this update on the decades long, mass hypnosis.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
All of the above provides the backdrop for biotech.
It’s interesting (then again, not really) how this sector’s nascent bear market’s being ignored by the financial press.
Instead of a breakout to the downside (as expected), yesterday the sector SPBIO, decided to test the 23.6%, retrace area.
Today’s early session was spent testing (to the upside) the resistance area.
Price action is now tentatively reversing; about to head lower again.
The hourly chart of LABD (3X inverse SPBIO) shows yesterday’s exit (well past the stop) and re-entry of the short position; not advice, not a recommendation.
For reasons that may be covered later, the stop was not in the market at the time.
In addition, there was a trading platform lock-up (on the broker’s side) at exit and re-entry. A series of amateur-like errors all around.
It’s just a reminder to all; when the market turns lower in earnest, brokers and their trade platforms may (probably will) become inoperative.
The whole event resulted in a significant ding to our ‘project account’
How quickly can this recover … we’ll see.
Below, we have the hourly chart again … but noted with what looks like a nascent trend.
That trend line was copied and re-positioned over prior LABD moves.
Note how this market repeats its characteristics. This angle of trend line has happened three times in the past month.
We’re back in position. The chart has been updated and the stop (now in the market, GTC) listed at 20.96 (above break-even):
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
Amandha Vollmer gives an excellent update on what was, what is, and what’s coming.
“They use the same playbook over and over again. This is what’s so stunning to me. If you have any semblance of research ability … this is all a lie. The cull is still coming.” (time stamp 1:05:15)
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
The Danger Point® 